Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Statistical issues in cost-effectiveness analysis.
DeLong
E R
ER
Community and Family Medicine, Duke University Medical Center, Durham, NC, USA.
Simons
T
T
D002317:Cardiovascular Agents / Q000191:economics*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data*; D019049:Developed Countries; D017850:Economics, Pharmaceutical; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans
D002317:Cardiovascular Agents